Discover Inovio Pharmaceuticals' Q1 2025 earnings call insights, including progress on INO-3107's BLA submission, reduced expenses, and groundbreaking ...

The Baloch Liberation Army (BLA) has claimed responsibility for 71 "coordinated attacks" at more than 51 locations across ...

The Balochistan Liberation Army reportedly claimed responsibility for 71 coordinated attacks at over 51 locations across ...

The Baloch Liberation Army claimed responsibility for seven attacks across Balochistan under 'Operation Herof 2.0,' targeting security posts, vehicles, and intelligence agents. The group vowed to ...

Amidst escalating tensions between India and Pakistan, Baloch writer Mir Yar Baloch declared Balochistan's independence, ...

Discover how Humacyte, Inc. (HUMA) is advancing with its Symvess commercial launch, overcoming challenges, expanding hospital evaluations, and ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

BLA's freedom struggle actions are part of coordinated attacks under Operation Herof 2.0 military exercise during which a total of 78 missions were carried out at 58 locations.

REGENXBIO Inc. (Nasdaq: RGNX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) seeking accelerated approval for clemidsogene ...

The National Institute of Allergy and Infectious Diseases (NIAID) plans to initiate phase 1 clinical trial of Capricor's ...

On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respirato ...

Laura Niklason; President, Chief Executive Officer, Director; Humacyte Inc. Dale Sander; Chief Financial Officer, Chief Corporate ...